The results from Phase 1 of the Troculeucel Clinical Trial demonstrated stable/improved outcomes in 90% of subjects, with no drug-related adverse events following troculeucel therapy. Troculeucel ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic a ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed ...

About the Trial TransCode's Phase 1 clinical trial is a multicenter ... is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based ...

No significant safety or dose limiting toxicities reported PK data from Cohorts 1 and 2 consistent with preclinical and Phase 0 trial results BOSTON, Feb. 6 ...

Creative Medical Technology (CELZ) announced initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the ...

SAB BIO, a clinical-stage biopharmaceutical company, announced it will host a webinar on January 28, 2025, to present topline data from its Phase 1 clinical trial for SAB-142, a novel treatment ...

Clinical trial design is a key aspect of the successful conduct of clinical trials. It involves deciding parameters such as the number of patients, the length of the trial, the comparator arm (in ...

This approval enables the commencement of a Phase 1 clinical trial, a highly anticipated step ... Dr. David Curiel, co-collaborator on the vector design and Professor of Radiation Oncology at ...

MAXONA Pharmaceuticals has officially emerged from stealth mode, announcing the successful completion of its U.S. Phase 1 ...

The Phase 1 clinical trial is comprised of two components. In the first component, 72 healthy volunteers have been enrolled in a blinded, randomized, placebo-controlled, staggered, parallel design ...